Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers

Clinical Pharmacology and Therapeutics

Volumn 74, Issue 2, 2003, Pages 170-177

  Markowitz, John S ^a   DeVane, C Lindsay ^a   Chavin, Kenneth D ^a   Taylor, Robin M ^a   Ruan, Ying ^a   Donovan, Jennifer L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; ALLIIN; ALPRAZOLAM; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; GARLIC EXTRACT; GUAIFENESIN; RITONAVIR; S ALLYLCYSTEINE; SAQUINAVIR;

ADULT; AREA UNDER THE CURVE; ARTICLE; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG URINE LEVEL; ENZYME ACTIVITY; FEMALE; GARLIC; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ALPRAZOLAM; AREA UNDER CURVE; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; DEXTROMETHORPHAN; DIETARY SUPPLEMENTS; FEMALE; GARLIC; HALF-LIFE; HUMANS; ISOENZYMES; MALE; SULFINIC ACIDS;

EID: 0043128560     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(03)00148-6     Document Type: Article

References (30)

1. Brevoort P. The booming US botanical market: a new overview. Herbalgram 1998;44:33-48.
2. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national study. JAMA 1998;280:1569-75.
3. Fugh-Berman A, Ernst E. Herb-drug interactions: review and assessment of report reliability. Br J Clin Pharmacol 2001;52:587-95.
4. Joshi BS, Kaul PN. Alternative medicine: herbal drugs and their critical appraisal - part I. In: Jucker E, editor. Progress in drug research. Basel (Switzerland): Birkhauser Verlag; 2002. p. 1-76.
5. Block E. The chemistry of garlic and onions. Sci Am 1985;252:114-9.
6. Foster BC, Foster MS, Vandenhoek S, Krantis A, Budzinski JW, Arnason JT, et al. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharmaceut Sci 2001;4:176-84.
7. Zou L, Harkey MR, Henderson GL. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 2002;71:1579-89.
8. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Fallon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002;34:234-8.
9. Gallicano K, Foster B, Choudhri S. Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2003;55:199-202.
10. Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, et al. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 1998;37:3594-601.
11. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, et al. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 2002;72:276-87.
12. Brosen K. Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry. Ther Drug Monit 1996;18:393-6.
13. Smith DA, Abel SM, Hyland R, Jones BC. Human cytochrome P450s: selectivity and measurement in vivo. Xenobiotica 1998;28:1095-128.
14. Venkatakrishnan K, Greenblatt DJ, von Moltke LL, Shader RI. Alprazolam is another substrate for human cytochrome P450-3A isoforms [letter]. J Clin Psychopharmacol 1998;18:256.
15. Gorski JC, Jones DR, Hamman MA, Wrighton SA, Hall SD. Biotransformation of alprazolam by members of the cytochrome P4503A isoforms. Xenobiotica 1999;29:931-44.
16. Schmider J, Brockmoller J, Arold G, Bauer S, Roots I. Simultaneous assessment of CYP3A4 and CYP1A2 activity in vitro with alprazolam and caffeine. Pharmacogenetics 1999;9:725-34.
17. Isaacsohn JL, Moser M, Stein EA, Dudley K, Davey JA, Liskov E, et al. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998;158:1189-94.
18. McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 1988;152:1089-94.
19. Lawson LD, Wang ZJ, Papadimitriou D. Allicin release under simulated gastrointestinal conditions from garlic powder tablets employed in clinical trials on serum cholesterol. Planta Med 2001;67:13-8.
20. Schmid B, Bircher J, Preisig R, Kupfer A. Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation. Clin Pharmacol Ther 1985;38:618-24.
21. Hoskins JM, Shenfield GM, Gross AS. Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping. J Chromatogr B 1997;696:81-7
22. Miller RL, DeVane CL. Alprazolam, alpha-hydroxy and 4-hydroxyalprazolam analysis in plasma by high performance liquid chromatography. J Chromatogr B 1988;430:180-6.
23. Greenblatt DJ, Wright CE. Clinical pharmacokinetics of alprazolam. Therapeutic implications. Clin Pharmacokinet 1993;24:453-71.
24. Donovan JL, DeVane C, Chavin KD, Taylor RM, Markowitz JS. Siberian ginseng (Eleutherococcus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos 2003;519-22.
25. Zanger U, Eichelbaum M. CYP2D6. In: Levy H, Thummel KE, Trager WF, Hansten PD, Eichelbaum M, editors. Metabolic drug interactions. New York: Lippincott Williams & Wilkins; 2000. p. 87-94.
26. Wrighton SA, Thummel KE. CYP3A. In: Levy H, Thummel KE, Trager WF, Hansten PD, Eichelbaum M, editors. Metabolic drug interactions. New York: Lippincott Williams & Wilkins; 2000. p. 115-34.
27. Miething H. Analysis of the volatile oil of garlic bulbs. Phytother Res 1988;2:149-51.
28. Perloff MD, von Moltke LL, Cotreau MM, Greenblatt DJ. Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr (-/-) mouse liver microsomes. Biochem Pharmacol 1999;57:1227-32.
29. Zeigler SJ, Sticher O. HPLC of S-alk(en)yl-L-cysteine derivatives in garlic including quantitative determination of (+)-S-allyl-L-cysteine sulfoxide (alliin). Planta Med 1989;55:372-8.
30. Lawson LD, Wang ZJ. Low allicin release from garlic supplements: a major problem due to the sensitivities of alliinase activity. J Agric Food Chem 2001;49:2592-9.